Great article explaining how the now preferred Covid treatment in the US of Chloroquine with the antibiotic azithromycin is associated with increased heart risk factors. My initial concern over the FDA announcement was that it was for such a specific use.
Now if Chloroquine is going to continue to be the preferred treatment then heart monitoring will also need to be undertaken.
Only hope now is that GMV can meet the demand for the patches.
GMV Price at posting:
7.2¢ Sentiment: Buy Disclosure: Held
